LGC
AGN

Laurel Grove Capital’s Allergan Inc AGN Stock Holding History

Laurel Grove Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-20,167
Closed -$4.29M – 110
2014
Q4 		$4.29M Sell
20,167
-2,650
-12% -$527K 2.45% 8
2014
Q3 		$4.07M Sell
22,817
-1,695
-7% -$282K 2.21% 12
2014
Q2 		$4.15M Sell
24,512
-100
-0.4% -$15.6K 2.3% 13
2014
Q1 		$3.05M Sell
24,612
-1,200
-5% -$146K 1.84% 20
2013
Q4 		$2.87M Sell
25,812
-655
-2% -$62.6K 1.7% 22
2013
Q3 		$2.39M Buy
26,467
+2,651
+11% +$238K 1.59% 21
2013
Q2 		$2.01M Buy
+23,816
New +$2.47M 1.43% 23

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Laurel Grove Capital's AGN Position: Q1 2015 in Review

Laurel Grove Capital sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 20,167 shares — an estimated $4.29M sold.

Laurel Grove Capital first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $4.29M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Laurel Grove Capital reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Laurel Grove Capital sold 20,167 Allergan Inc shares in Q1 2015, an estimated $4.29M.
  • Laurel Grove Capital first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Laurel Grove Capital's Allergan Inc position peaked at $4.29M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Laurel Grove Capital's 13F filing for Q1 2015, filed 14 Apr 2015.